| Prev Close: | 3.01 |
|---|---|
| Open: | 2.97 |
| Bid: | 2.86 x 700 |
| Ask: | 2.93 x 300 |
| 1y Target Est: | 9.00 |
| Beta: | 1 |
| Next Earnings Date: | 29-Jul-13 |
| Day's Range: | 2.90 - 3.00 |
|---|---|
| 52wk Range: | 2.66 - 7.00 |
| Volume: | 23,399 |
| Avg Vol (3m): | 144,325 |
| Market Cap: | 19.09M |
| P/E (ttm): | N/A |
| EPS (ttm): | -1.31 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Revisiting Oculus: Earnings Do Little To Ease The Painat Seeking Alpha(Tue, Jun 18)
- Oculus Innovative Sciences Management Discusses Q4 2013 Results - Earnings Call Transcriptat Seeking Alpha(Thu, Jun 13)
- Oculus Innovative Sciences Reports Revenues of $15.5 Million for Fiscal Year 2013, Product Revenue Up 23 PercentGlobeNewswire(Thu, Jun 13)
- OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial ConditionEDGAR Online(Thu, Jun 13)
- Q4 2013 OCULUS INNOVATIVE SCIENCES INC Earnings Release - After Market CloseCCBN(Thu, Jun 13)
- 5 Hated Earnings Stocks That Deserve Your Loveat TheStreet(Tue, Jun 11)
- OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in DirectorsEDGAR Online(Fri, Jun 7)
- Oculus Innovative Sciences Announces Two Key Agreements With Company's Subsidiary, Ruthigen, Inc.GlobeNewswire(Thu, Jun 6)
- [video] Can Virtual Reality Make You a Better Person?at MarketWatch(Wed, Jun 5)
- OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Regulation FD DisclosureEDGAR Online(Thu, May 30)
- OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Regulation FD DisclosureEDGAR Online(Wed, May 29)
- Oculus Announces Confidential Submission of Draft Registration Statement for Initial Public Offering to Securities and Exchange Commission by Its Subsidiary Ruthigen, Inc.GlobeNewswire(Tue, May 28)
- Oculus Innovative Sciences Announces Fiscal Fourth Quarter 2013 Financial Results and Conference CallGlobeNewswire(Thu, May 23)
- Bypassing Biotechs and Focusing on the Overlooked Medical Device Space: An Expert Portfolio Manager Discusses His Contrarian Approach to InvestingWall Street Transcript(Fri, May 17)
- Short On Oculus: Wound Care Company Has Left Dirty Scarsat Seeking Alpha(Tue, May 7)
Press Releases
- Oculus Innovative Sciences Reports Revenues of $15.5 Million for Fiscal Year 2013, Product Revenue Up 23 PercentGlobeNewswire(Thu, Jun 13)
- Oculus Innovative Sciences Announces Two Key Agreements With Company's Subsidiary, Ruthigen, Inc.GlobeNewswire(Thu, Jun 6)
- Oculus Announces Confidential Submission of Draft Registration Statement for Initial Public Offering to Securities and Exchange Commission by Its Subsidiary Ruthigen, Inc.GlobeNewswire(Tue, May 28)
Reports
- ValuEngine Industry Report for Medical/dental-suppliesValuEngine, Inc.(Jun 19)
- Oculus Innovative SciencesS&P Capital IQ Quantitative Report(Jun 15)
- OCULUS INNOVATIVE SCIENCES INC (OCLS) 12-months forecastPechala's Reports(Jun 15)